Vanguard Portfolio Management (SRPT) discloses 8.05% beneficial stake in Sarepta

Vanguard Portfolio Management LLC has disclosed an 8.05% beneficial ownership stake in Sarepta Therapeutics Inc. (SRPT) through an amended Schedule 13G filing. As of June 30, 2026, Vanguard beneficially owns 8,499,421 shares, holding sole voting power over 121,951 shares and sole dispositive power over all 8,499,421 shares. This passive investment is held on behalf of various affiliated entities and managed accounts, with no single individual having more than a 5% interest within these holdings.